scholarly journals Beyond ADHD and narcolepsy: psychostimulants in general psychiatry

2009 ◽  
Vol 15 (4) ◽  
pp. 297-305 ◽  
Author(s):  
Bradley Ng ◽  
Angela O'Brien

SummaryPsychostimulants (dexamphetamine, methylphenidate, modafinil) reduce fatigue, promote alertness and wakefulness, and have possible mood-enhancing properties. In modern psychiatric practice, their use has been limited to attention-deficit hyperactivity disorder and sleep disorders such as narcolepsy. Despite this, research has continued into psychostimulant use in general psychiatry, especially in the treatment of depression and fatigue. This article reviews the recent literature regarding psychostimulant use in general and consultation-liaison psychiatry. Although psychostimulants continue to attract clinical research, there is currently not enough evidence to recommend their routine use for general psychiatric conditions.

2020 ◽  
Vol 81 (3) ◽  
pp. 1-11
Author(s):  
Joe Johnson ◽  
Sarah Morris ◽  
Sanju George

Attention deficit hyperactivity disorder is a persistent, pervasive neurodevelopmental disorder, characterised by the core features of hyperactivity, impulsivity and inattention. While previously thought to be a condition that only affects children, it is now well recognised that in a significant proportion of cases both symptoms and associated impairment will persist into adulthood. Nevertheless, many cases are missed or misdiagnosed because of the lack of awareness of attention deficit hyperactivity disorder as a potential diagnosis in adults, the number of symptoms that overlap with other psychiatric conditions, and the high rates of comorbidity. However, once correctly diagnosed, attention deficit hyperactivity disorder responds well to treatment, particularly pharmacological intervention. This article gives an overview of attention deficit hyperactivity disorder with special emphasis on the diagnosis and pharmacological treatment of attention deficit hyperactivity disorder in adults.


2011 ◽  
Vol 26 (S2) ◽  
pp. 1718-1718
Author(s):  
R.M. Freire Lucas

Attention-deficit hyperactivity disorder (ADHD) is a common, genetically transmitted neurological disorder, with onset in childhood, probably mediated in part by decreased brain dopaminergic functioning. Prevalence and natural history data suggest that of the 3–10% of children diagnosed with ADHD, one-to two-thirds continue to manifest appreciable ADHD symptoms as adults, interfering in academic, professional, affective and social life. Recently, several studies have challenged DSM-IV's requirement of ADHD onset before age 7 with the questioning of the validity of the age-at onset criterion.Based on the description of a late onset ADHD clinical case (onset after the age of 7), this presentation shows a review on the recent literature about ADHD, addressing how ADHD in adults can be readily diagnosed and treated using the Wender Utah diagnostic criteria to identify adult characteristics of the disorder. This work also addresses core hypotheses of etiology and treatment. The study was based on a revision of articles from Medline/PubMed, PsycINFO and from books published in the last years.


Author(s):  
Alessandro Zuddas ◽  
Sara Carucci

Any treatment plan for attention-deficit/hyperactivity disorder (ADHD) must be based on a comprehensive diagnostic evaluation, being aware of possible concomitant medical or psychiatric conditions. Rather than focusing just on the disorder, subjects should be treated as individuals in their social context; baseline symptom severity, impairments, and strengths should be recorded, as well as any environmental risks and/or protective factors. This chapter presents how to develop a treatment plan and offers an extensive update on current available treatments and the safety of ADHD medications, with practical implications for clinicians.


1989 ◽  
Vol 40 (7) ◽  
pp. 699-707
Author(s):  
Robinson J. Munoz-Millan ◽  
C. Richard Casteel

Sign in / Sign up

Export Citation Format

Share Document